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Abstract
Background: TRPV6 ion channels are key mediators of regulated transepithelial absorption of Ca
2+ within the small
intestine. Trpv6
-/- mice were reported to have lower bone density than wild-type littermates and significant disturbances in
calcium homeostasis that suggested a role for TRPV6 in osteoblasts during bone formation and mineralization. TRPV6 and
molecules related to transepithelial Ca
2+ transport have been reported to be expressed at high levels in human and mouse
osteoblasts.
Results: Transmembrane ion currents in whole cell patch clamped SaOS-2 osteoblasts did not show sensitivity to ruthenium
red, an inhibitor of TRPV5/6 ion channels, and
45Ca uptake was not significantly affected by ruthenium red in either SaOS-2
(P=0.77) or TE-85 (P=0.69) osteoblastic cells. In contrast, ion currents and
45Ca uptake were both significantly affected in a
human bronchial epithelial cell line known to express TRPV6. TRPV6 was expressed at lower levels in osteoblastic cells than
has been reported in some literature. In SaOS-2 TRPV6 mRNA was below the assay detection limit; in TE-85 TRPV6 mRNA
was detected at 6.9061.9610
25 relative to B2M. In contrast, TRPV6 was detected at 7.763.0610
22 and 2.3860.28610
24
the level of B2M in human carcinoma-derived cell lines LNCaP and CaCO-2 respectively. In murine primary calvarial
osteoblasts TRPV6 was detected at 3.8060.24610
25 relative to GAPDH, in contrast with 4.361.5610
22 relative to GAPDH
in murine duodenum. By immunohistochemistry, TRPV6 was expressed mainly in myleocytic cells of the murine bone
marrow and was observed only at low levels in murine osteoblasts, osteocytes or growth plate cartilage.
Conclusions: TRPV6 is expressed only at low levels in osteoblasts and plays little functional role in osteoblastic calcium
uptake.
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Introduction
Skeletal mineral includes a dynamic store of calcium ions that
can be accessed rapidly in the absence of dietary sources to
maintain the plasma concentration within tightly regulated limits.
Calcium homeostasis involves both active and passive absorptive
mechanisms in the intestine, both constitutive and regulated
reabsorptive processes in the kidney and the exchange between
mineralized and ionized forms of calcium in bones [1,2]. Two of
the key molecules that mediate intestinal absorption and renal
reabsorption of Ca
2+ have recently been identified. TRPV6, a
Ca
2+ selective member of the transient receptor potential vanilloid
class of ion channels, was detected in epithelial cells of the small
intestine and was described as ‘‘the gatekeeper’’ of active Ca
2+
absorption from the diet [3,4,5,6]. TRPV5, a closely related
homologue, was identified as the principal mediator of regulated
Ca
2+ reabsorption in the distal convoluted tubules of the kidney
[7]. Ca
2+ is transferred from the intestinal or the renal tubular
lumen into epithelial cells via these key ion channels which are
expressed on the apical cell surface, transported through the cell
complexed with the Ca
2+ binding proteins calbindin–D9K and –
D28K, and is extruded through the basolateral membrane via the
Ca
2+ exchangers NCX1 and PMCA1b [8,9,10].
Mice in which Trpv6 is ablated globally (Trpv6
-/-)w e r e
reported to exhibit 60% lower intestinal Ca
2+ absorption,
secondary hyperparathyroidism, a greater than 2-fold higher
Ca
2+ excretion and 9.3% lower femoral bone mineral density
( B M D )c o m p a r e dw i t hw i l dt y p e( W T )l i t t e r m a t e s[ 1 1 ] .T h el o w
BMD in these mice is consistent with the proposed role of
TRPV6 in intestinal and renal absorption of Ca
2+ as a
consequence of reduced Ca
2+ availability for mineralization.
However, in their study, Bianco et al. [11] were unable to rescue
the BMD of Trpv6
-/- mice with a high (2%) Ca
2+ diet and the
relative increase in BMD in Trpv6
-/- mice on this diet was lower
than in wild-type littermates [11]. On a low Ca
2+ diet, Trpv6
-/-
mice did not increase their urinary deoxypirodinoline excretion.
The authors argued these findings showed that the bones and
kidneys of Trpv6
-/- mice do not respond to parathyroid hormone
PLoS ONE | www.plosone.org 1 November 2011 | Volume 6 | Issue 11 | e28166(PTH) and 1,25-dihydroxy vitamin D3 (1,25D3), implying a role
for TRPV6 in both tissues.
A number of previous studies report that osteoblasts express all
the key molecular components of the ‘‘transepithelial’’ calcium
transport pathway. Balmain et al. [12] provided the first immuno-
histological evidence that calbindin–D9K is expressed by both
osteoblasts and osteocytes and that its synthesis in trabecular bone is
regulated by 1,25D3. Berdal et al. [13] showed that both calbindin–
D9K and –D28K are expressed in rat osteoblasts, while Faucheux
et al. [14] demonstrated the production of calbindin-D28K during
mineralization inhumanbone marrowstromal cells.Lundquistetal.
[15] demonstrated the expression of three isoforms of the NCX1
Na
+/Ca
2+ exchanger in primary rat odontoblasts and osteoblasts
and in a rat and a human osteoblastic cell line. Meszaros and Karin
[16] showed that primary rat osteoblasts and osteoblast-like
osteosarcoma cells express PMCA1b, an isoform of the plasma
membrane calcium ATPase. Weber et al. [17] demonstrated that
ECaC2 (TRPV6) and calbindin-D9K, but not ECaC1 (TRPV5) or
calbindin-D28K, were strongly expressed in primary murine
calvarial osteoblasts and whole bones. Nijenhuis et al. [18] also
detected mRNA for TRPV6 in whole murine bone. Taken
together, the evidence suggested that a complete mechanism existed
fortheinvolvementofTRPV6inosteoblasticcalciumhandling,and
led us to hypothesize that transmembrane Ca
2+ ion currents and
Ca
2+ uptake in osteoblastic cells would be sensitive to ruthenium
red, an inhibitor of both TRPV6 and TRPV5 [19]. We attempted
to characterize the contribution of TRPV6 to Ca
2+ membrane
currents in whole cell patch clamped SaOS-2 human osteoblastic
cells but we failed to demonstrate ruthenium red sensitivity. We also
did not observe an effect of ruthenium red on
45Ca uptake in either
SaOS-2 or TE-85 osteoblastic cells. On further investigation we
found little or no expression of TRPV6 in a variety of human and
murine osteoblastic cells using both qPCR and immunohistochem-
istry. We show here that TRPV6 is not widely expressed in
osteoblastic cells and that it plays little role in osteoblastic Ca
2+
uptake. Our functional data are fully consistent with a recent report
that TRPV6 plays little role in bone mineralization [20], but our
TRPV6 expression data contrast strongly with that of Weber et al.
[17] and van der Eerden et al. [20].
Results
Electrophysiological characterization of membrane
currents
Although whole cell transmembrane currents in ten out of
fourteen patch clamped SaOS-2 osteoblastic cells showed an
apparent sensitivity to 100 mM ruthenium red (Figure 1, A-B),
mean transmembrane currents (normalized for capacitance) were
not significantly decreased by 100 mM ruthenium red either in
2 mM extracellular Ca
2+ ([Ca
2+]O; P=0.21, n=5; Figure 1, C) or
in 0 mM [Ca
2+]O (P=0.20, n=5; data not shown). Under the
experimental conditions, whole cell transmembrane currents
showed no rectification and the relationship between current and
voltage was best fitted to a straight line (Figure 1, C). In contrast,
mean transmembrane currents (normalized for capacitance) in the
human bronchial epithelial cell line 16HBE14o-, which we have
previously shown to express TRPV6 [21] did display sensitivity to
100 mM ruthenium red (Figure 1, D, P=0.00018), and the
ruthenium red sensitive currents in these cells accounted for 31 6
4% (mean 6 SEM) of the total current at 60 mV holding potential.
Assessment of TRPV ion channel mediated
45Ca uptake
Ruthenium red (100 mM) had no significant effect on uptake of
45Ca by SaOS-2 cells (P=0.77) or TE-85 cells (P=0.69; Figure 2),
either in the absence or presence of 10 nM 1,25D3. Treatment
with 1,25D3 for seven days resulted in a statistically significant
increase in
45Ca uptake in SaOS-2 cells (P=0.04) that was not
sensitive to ruthenium red (Figure 2, A). A statistically significant,
ruthenium red insensitive, decrease in
45Ca uptake was observed
in TE-85 cells (P=0.03) in response to 24 h treatment with
1,25D3 (Figure 2, B). In contrast, 16HBE14o- cells showed
sensitivity to ruthenium red (Figure 2, C) and the ruthenium red
sensitive uptake accounted for 2765% of the total uptake.
TRPV6 gene transcript expression in cells and tissues
We selected B2M as the reference for human TRPV6 mRNA
expression as it was the least variable of three reference genes
tested in the samples we analyzed (Figure 3, A). For murine
TRPV6 mRNA expression, we selected GAPDH as the least
variable reference (data not shown). TRPV6 mRNA was readily
detected in LNCaP and CaCO-2 cells, which displayed the highest
levels for the human cells we examined (7.763.0 6 10
22 and
2.460.3610
24 relative to B2M; Figure 3, B). Treatment for 12 h
with 1,25D3 (10 nM) resulted in a significant (P=0.023) up
regulation of TRPV6 mRNA in CaCO-2 cells by nearly 10-fold
(Figure 3, B). In TE-85 cells, mRNA for TRPV6 was expressed
near the limit of detection, at 6.961.9 6 10
25 relative to B2M.
TRPV6 transcript levels and were not altered by treatment with
1,25D3 in these cells (P=0.815; Figure 3, B). In SaOS-2 cells,
TRPV6 mRNA expression was undetectable within 40 qPCR
cycles, whether under basal conditions or following stimulation
with 1,25D3 (data not shown). TRPV6 mRNA expression was not
significantly altered (P=0.842) in TE-85 cells grown in osteogenic
medium for 7 days, and remained undetectable in SaOS-2 cells
with this treatment (data not shown). TRPV6 mRNA was readily
detected in murine duodenum at between 1.3 and 6.5 6 10
22
relative to GAPDH (Figure 3, C). In murine primary calvarial
osteoblasts, TRPV6 mRNA was detected at 3.8360.24610
25
relative to GAPDH (Figure 3, C).
Immunohistochemistry for TRPV6 in cells and tissues
TRPV6 expression, revealed by DAB immunoperoxidase
staining, was considerably stronger in LNCaP cells (Figure 4, A)
than in TE-85 cells (Figure 4, B) when cultured cells were
processed simultaneously. In murine duodenum, staining for
TRPV6 was strong in enterocyte cells of the intestinal villi
(Figure 4, D&E) with a concentration of expression at the apical
cell membrane (luminal facing) at the tips of the villi (Figure 4, E).
In contrast, there was little or no staining for TRPV6 in osteoblasts
either at the endocortical surface (Figure 4, F) or on trabecular
bone (Figure 4, G&H). TRPV6 was not detected in cortical or
trabecular osteocytes (Figure 3, F-H) nor in the growth plate
(Figure 4, I). In contrast, strong staining was observed in a
proportion of cells throughout the bone marrow, principally in
cells with multilobular nuclei (Figure 4, F-I).
Discussion
Our initial aim was to characterize the contribution of TRPV6
ion channels to Ca
2+ currents in whole cell patch clamped SaOS-2
osteosarcoma cells. We selected SaOS-2 cells for our electrophys-
iological studies as they have been widely used as a model of
differentiated osteoblast lineage cells that can form mineralized
matrix both in vitro [22] and in vivo [23]. We used ruthenium red to
differentiate TRPV6-mediated ion currents from other Ca
2+
currents as it has been reported as an inhibitor of TRPV ion
channels, with IC50 values of 961 mM and 121613 nM for
TRPV6 and TRPV5, respectively [19]. We are aware of the
Little Function for TRPV6 in Osteoblasts
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especially since it virtually abolishes ryanodine receptor mediated
Ca
2+ currents in rat and rabbit osteoclasts at similar concentra-
tions to what we have used here [24]. However, we did not detect
any ruthenium red sensitive transmembrane currents in SaOS-2
cells. In contrast, averaged and normalized whole cell currents in
16HBE14o- cells, which we have previously shown to express
TRPV6 [21], did show sensitivity to ruthenium red. However, in
the 16HBE14o- cell line the reversal potential was close to 0 mV
and was not characteristic of TRPV6 Ca
2+ ion channels observed
in overexpression systems such as Chinese hamster ovary (CHO)
cells [25], for which a value of 4965 mV has been reported. To
date, there are no publications describing the electrophysiological
characteristics of native TRPV6 ion channels in any cell type and
therefore the difference in the reversal potential from our
16HBE14o- cell data and that from CHO cells remains unclear.
Further studies are needed on the requirement and role of
accessory molecules which may modulate the behavior and
electrophysiological characteristics of TRPV6 ion channels in
their native configuration. In both SaOS-2 and 16HBE14o- cells,
the magnitude of the currents and the linearity of the current-
voltage relationship could suggest leak current arising from poor
patch sealing but the time-dependent inactivation of channels
evident in our traces argues against this (see Figure 1 A, +100 mV
trace). Few studies have characterized osteoblastic cells by whole
cell patch clamping. In the only published study using whole cell
patch clamping in SaOS-2 cells, Laketic-Ljubojevic et al. [26]
demonstrated the presence of functional N-methyl D-aspartate
receptors. Whole cell and excised patch voltage-clamp studies in a
variety of other osteoblastic and osteogenic cells have demonstrat-
ed a variety of ion conductances, including a transient outward
rectifying K
+ conduction, a calcium activated K
+ conductance,
chloride and phosphate mediated conductances, and stretch
activated cation channels [27,28]. Our pipette solution contained
Cs
+ to block K
+ ion channels and we therefore expect that the
main conductance in SaOS-2 cells was mediated by non-selective
cation and chloride channels. Our laboratory has previously
shown that the association of TRPV6 with annexin-2/S100A10
and the formation of annexin-2/S100A10 complex in airway and
gut epithelia are both dependent on cyclic 39,59-adenosine
monophosphate (cAMP) and cAMP-dependent protein kinase
(PKA, EC 2.7.1.37) [21], and that calcium influx in Caco-2 cells is
attenuated by PKA and calcineurin A inhibition [21]. We
therefore included forskolin and IBMX in our bath solution to
elevate cAMP and maximise the opportunity for observing
TRPV6-mediated currents. Increasing cAMP may also have
affected other cAMP-dependent ion channels, which might
account for the difference in magnitude of native currents between
our studies and that previously reported in SaOS-2 cells by
Laketic-Ljubojevic et al. [26].
We did not observe a significant effect of ruthenium red on
45Ca
uptake in either SaOS-2 or TE-85 cells. In contrast, uptake in
TRPV6-expressing 16HBE14o- cells was significantly inhibited by
ruthenium red, accounting for approximately 27% of the total
uptake. While Ca
2+ uptake in both SaOS-2 and TE85 cells was
insensitive to ruthenium red, we observed significant ruthenium
Figure 1. Currents in whole cell voltage-clamped SaOS-2 and 16HBE14o- cells. A, B: typical traces obtained from the same SaOS-2 cell in
2 mM [Ca
2+]O without (A) and with (B) 100 mM ruthenium red. C: Currents for SaOS-2 cells (mean 6 SEM; n=5) in 2 mM [Ca
2+]O without (open
symbols) and with (solid symbols) 100 mM ruthenium red. A straight line adequately fits both conditions (P=0.21; comparison of both datasets using
the extra sum of squares F-test). D: Currents for 16HBE14o- cells (mean 6 SEM; n=15) in 2 mM [Ca
2+]O without (open symbols) and with (solid
symbols) 100 mM ruthenium red. (P=0.027; extra sum of squares F-test).
doi:10.1371/journal.pone.0028166.g001
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2+ in these cells in
response to treatment with 1,25D3, suggesting that 1,25D3
modulates the expression or activity of calcium selective ion
channels other than TRPV6 in these cells. We did not assess
uptake in osteoblastic cells under more differentiated conditions
Figure 2.
45Ca uptake assays. Uptake of
45Ca by SaOS-2 cells (A:
P=0.76) , TE-85 cells (B: P=0.69) and 16HBE14o- cells (C: P=0.0003) in
the absence (open bar) and presence (solid bar) of 100 mM ruthenium
red. Treatment of SaOS-2 cells with 1,25D3 (10 nM for 7 days) resulted in
an increase in
45Ca uptake (P=0.04) that was insensitive to ruthenium
red. Treatment of TE-85 cells with 1,25D3 (24 h) resulted in a ruthenium
red insensitive decrease in
45Ca uptake (P=0.03). n=3 experiments
with 6 replicates per treatment for all cell lines. * P,0.05, n.s. not
statistically significant.
doi:10.1371/journal.pone.0028166.g002 Figure 3. TRPV6 mRNA expression in human and murine cells
and tissues. A: Variation in reference gene expression in human cDNA
templates. B: TRPV6 mRNA expression in human cells, relative to B2M.
D3: 12 h with 10 nM 1,25D3. Data are individual measures with mean 6
SEM. C: TRPV6 mRNA expression in murine duodenum and in primary
murine calvarial osteoblasts, relative to B2M (n=3 for duodenum and
n=4 for calvarial osteoblasts). * P,0.05, n.s. not statistically significant.
doi:10.1371/journal.pone.0028166.g003
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from the binding of calcium to extracellular proteins and mineral
that are generated over time in these cultures.
The results from our two functional assays for TRPV6 are
consistent with the conclusions of the recent study by van der
Eerden et al. [20] who overexpressed TRPV6 in a simian virus-
immortalized human fetal osteoblast-like (SV-HFO) cell line and
showed that it had no effect on mineralization in vitro. The lack of
ruthenium red sensitivity in our assays led us to question whether
TRPV6 was expressed in the osteoblastic cells used in our studies.
Using a qPCR assay, we observed that TRPV6 transcripts were
below the assay’s limit of detection in SaOS-2 cells. TRPV6
mRNA expression was also very low in the human osteoblastic cell
line TE85 and in primary murine calvarial osteoblasts, contrasting
with earlier reports in the literature of TRPV6 expression in
human bone [18] and murine osteoblasts [17]. The levels of
TRPV6 transcripts measured in our assays also contrast strongly
with the recent data from van der Eerden et al. [20] who report
TRPV6 transcripts at equal or higher levels to GAPDH in murine
osteoblasts, in SV-HFO cells and in samples of human and murine
femoral bone from which the bone marrow was removed. In our
qPCR assays, GAPDH and B2M were expressed at levels within a
factor of 10-fold of each other in most templates. Our values for
TRPV6 expression are between 10
24 and 10
25 the level of B2M
or GAPDH in human and murine osteoblasts respectively, which
equate to between 10
5- and 10
6-fold lower than those reported in
osteoblasts by van der Eerden et al. [20]. The same laboratory has
reported TRPV6 mRNA levels in murine bone at around 50% of
the level in murine duodenum [18], while we detected TRPV6 in
murine osteoblasts at about 0.1% of the level in murine
duodenum. This contrast is surprising since we have used identical
primers and probe for TRPV6 in our qPCR assays [18,20]. Our
data for TRPV6 expression is consistent with the findings of Abed
et al. [29], who did not detect TRPV6 in a variety of human and
murine osteoblastic cells, but showed that other TRPV ion
channels are present. Our data for TRPV6 mRNA levels in cells
and tissue used as positive controls, i.e. LNCaP and CaCO-2 cells
or murine duodenum, is consistent with other publications
[4,30,31], and our data from primary murine calvarial osteoblasts
relative to murine duodenum is consistent with data from Lieben
et al. [31].
Despite the differences that we report in the level of gene
expression, neither we nor van der Eerden et al. [20] could
demonstrate an up regulation of TRPV6 in osteoblasts by 1,25D3.
In our experiments, short-term treatment of SaOS-2 and TE85
cells with 1,25D3 for 12 hours had no effect on TRPV6 mRNA
expression, while a similar treatment up-regulated TRPV6
expression in CaCO-2 cells. Seven days of treatment with an
osteogenic medium containing ascorbate, dexamethasone and b-
glycerophosphate also had no significant effect on TRPV6
expression either in SaOS-2 or TE85 cells. In their study, van
der Eerden et al. [20] also showed that 1,25D3 did not regulate
TRPV6 expression in either mineralizing or non-mineralizing
cultures of human osteoblast-like cells.
Figure 4. TRPV6 protein expression in bone cells and tissues. A, B: TRPV6 expression in LNCaP (A) and TE-85 (B) cells. An inset image shows
staining with normal goat IgG (1 mg/mL) in each cell line. The slides in A and B were processed simultaneously. C: Staining with normal goat IgG
(1 mg/mL) in mouse bone. D, E: TRPV6 expression in normal murine duodenum (positive control). F-I: TRPV6 expression in normal murine bone.
Tissues from 6-week old male C57Bl/6J mice were fixed in 10% buffered formalin for 48 hours. Bones were decalcified for 4 weeks in EDTA/PFA.
Images are representative of three mice. Slides in C-I were processed simultaneously. Scale bar: 50 mm in all panels.
doi:10.1371/journal.pone.0028166.g004
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showed that TRPV6 is principally expressed in bone marrow
cells with multilobular nuclei suggestive of a myleocytic/leukocytic
lineage. We detected little or no expression of TRPV6 in
osteoblasts, osteocytes or growth plate chondrocytes in sections
of murine bone. The high level of expression in bone marrow cells
could possibly account for TRPV6 being detected in bone samples
from which the marrow has largely been removed [20], but which
inevitably will retain some traces of marrow cells. In sections of
murine duodenum, processed as a positive control under identical
conditions as and simultaneously with the bone samples, the
distribution of staining for TRPV6 was consistent with its role in
intestinal calcium uptake, with preferential staining of cells towards
the tips of the intestinal villi and with a distinct distribution on
apical cell membranes. Our findings in murine bone again
contrast with the recent report of van der Eerden et al. [20] who
have described ‘‘apical’’ TRPV6 expression in osteoblasts within a
section of human (osteoarthritic) trabecular bone using an
immunofluorescence method. Although we have used different
antibodies and methods of immunodetection, on Western blots
both antibodies appear to detect TRPV6 as two distinct bands
[18,21], that correspond to the core and glycosylated forms [18].
While our method using enzyme histochemical staining to reveal
TRPV6 may not be particularly sensitive, our protocol allowed
visualization of TRPV6 expression throughout the whole envi-
ronment of bone, under conditions where its expression in murine
duodenum was readily detected. Our data demonstrate that
osteoblastic expression of TRPV6 is very low in relation to the
level seen in the bone marrow myelocytic cells. The use of confocal
microscopy combined with a secondary antibody labeled with
QdotsH in the report by van der Eerden et al. [20] would provide
very high sensitivity for detection of TRPV6 in their human bone
sample, but it is difficult to relate their observed TRPV6
expression in osteoblasts with that in other cells in their bone
sample as it would appear that the bone marrow may have been
removed from their specimen and there is therefore little cellular
or tissue context in their figure.
Although the level of expression of TRPV6 in osteoblasts is
questioned here, there is no clear evidence either from our
functional assays or from other laboratories that TRPV6 acts as a
Ca
2+ selective ion channel in osteoblastic cells. Our electrophys-
iological and calcium uptake assays show that TRPV6 contributes
little to calcium handling in osteoblasts. While the initial
phenotypic description of Trpv6
-/- mice [11] suggested a potential
role for TRPV6 within bone, a more recent and extensive study
[31] has subsequently shown that bone mass is normal in both
young and ageing Trpv6
-/- mice receiving a normal (1%) calcium
diet. In mice with a restricted (,0.02%) calcium diet from
weaning, the changes in bone formation and mineralization
occurred equally in Trpv6
-/- and wild-type mice, as an indirect
consequence of the limited calcium supply [31]. Our data supports
the conclusion that TRPV6 plays little physiological role in
osteoblastic cells, and that the principal functions of TRPV6 in
calcium homeostasis are to mediate active calcium uptake and
reuptake in intestinal and renal epithelial tissues [31].
Materials and Methods
Materials
Gibco brand cell culture media, supplements and trypsin-
EDTA solution were purchased from Fisher Scientific, UK.
Recombinant human macrophage colony stimulating factor
(MCSF) and recombinant murine receptor activator of nuclear
factor k-B ligand (RANKL) were purchased from Peprotech EU.
Stock solutions of these cytokines were prepared at 5 mg/mL in
sterile phosphate buffered saline (1x PBS; Gibco, UK) containing
0.1% (v/v) bovine serum albumin (BSA; Sigma, UK). RNA
Superscript III reverse transcriptase and oligo-dT20 were pur-
chased from Fisher Scientific. Universal qPCR Mastermix was
purchased from Applied Biosystems (UK). For immunohistological
studies a goat polyclonal IgG against TRPV6 (sc-31445) was
purchased from Santa Cruz Biotechnology, USA, and a
horseradish peroxidase-conjugated rabbit anti-goat IgG (A5420)
was purchased from Sigma-Aldrich, UK. Rabbit serum, normal
goat IgG and 3,39-diaminobenzidine (DAB) peroxidase substrate
solution were purchased from Vector Laboratories, Burlingame,
USA and DePeX Mounting Medium purchased from VWR
International, UK.
45CaCl2 was purchased from Amersham, UK.
All other reagents were purchased from Sigma-Aldrich, UK unless
otherwise stated.
Cell lines
The human bronchial epithelial cell line 16HBE14o- was
obtained from Dr. DC Gruenert, California Pacific Medical
Center Research Institute, San Francisco, CA, USA. All other cell
lines originated from the American Type Culture Collection and
were purchased through LGC (UK). The human osteosarcoma-
derived HOS/TE-85 osteoblastic cell line, the prostate carcinoma-
derived LNCaP and the colon carcinoma-derived CaCO-2 cell
lines were grown in Dulbecco’s Modified Eagle’s Medium
(DMEM) containing GlutamaxH, supplemented with 10% FCS
(Biowhittaker, Maryland, USA), 100U/mL penicillin and 100 mg/
mL streptomycin. CaCO-2 cells were additionally supplemented
with 1% (v/v) 100x non-essential amino acids and 0.06% (v/v)
gentamicin. The human osteosarcoma-derived SaOS-2 osteoblas-
tic cell line was grown in a-MEM supplemented as for TE-85 cells.
16HBE14o- cells were grown in medium 199 containing 10% fetal
calf serum, penicillin (100 U/ml) streptomycin (0.1 mg/ml) and l-
glutamine (2 mM) as described previously [21]. Media prepara-
tions as described here are referred to as complete growth medium
below. Cells were maintained at 37C in tissue culture grade flasks
or multiwell dishes (Corning Incorporated, USA) in a humidified
atmosphere of 95% air and 5% CO2.
Electrophysiology
SaOS-2 and 16HBE14o- cells were plated at low density on
13 mm plastic coverslips (Agar Scientific, UK) in a 10 cm tissue
culture dish (Iwaki, Ashai Glass Co., Japan). Whole-cell patch
clamp experiments [32] were performed in a Perspex bath clasped
onto the stage of an Olympus IX70 inverted microscope. Thirty
minutes prior to patching, a coverslip was transferred to the
Perspex bath which contained an extracellular solution consisting
of 120 mM CsCl, 10 mM HEPES titrated to pH 7.4 with
CsOH, 10 mM forskolin and 100 mM 3-isobutyl-1-methylxanthine
(IBMX). The pipette solution consisted of 20 mM CsCl,
100 mM Cs aspartate, 10 mM HEPES titrated to pH 7.4 with
CsOH, 1 mM MgCl2, 10 mM 1,2-bis(o-aminophenoxy)ethane-
N,N,N’,N’-tetra acetic acid and 4 mM Na2ATP in dH2O, and
either 0 mM (low) or 2 mM (high) CaCl2. Potentials were driven
by v6 pCLAMP software with a Digidata 1200 Series interface
(Axon Instruments, UK) for membrane voltage steps between
2100 mV and +100 mV from a holding potential of 240 mV.
High frequency electrical noise was reduced by passing signals
through an 8-pole Low Pass filter at 5 KHz, and by placing a
shield in front of the microscope. On achieving whole-cell
configuration, cells were perfused under gravity with extracellular
solution and current at steady state was recorded with a L/M
EPC7 amplifier (Heka Electronik, Germany) with recordings
Little Function for TRPV6 in Osteoblasts
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patched cell at steady state was also recorded. The contribution of
TRPV6 channel activity to whole cell current was assessed by
perfusing cells with extracellular solution supplemented with
ruthenium red (100 mM) [19,33]. Ca
2+ selectivity of whole-cell
currents was assessed by perfusing cells with extracellular solution
containing 5 mM mannitol in place of 2 mM CaCl2. The
ruthenium red-sensitive current was calculated as the whole-cell
current in the presence of ruthenium red subtracted from the
current obtained in the absence of ruthenium red at each potential
in both extracellular solutions.
Calcium uptake assays
For
45Ca uptake assays, SaOS-2 TE-85 and 16HBE14o- cells
were plated in 12-well multi-well plates at 2610
5 cells per well.
SaOS-2 cells were incubated for 2 days in complete growth
medium and thereafter supplemented with dexamethasone
(10 nM), b-glycerophosphate (10 mM) and ascorbic acid
(500 ng/mL) to promote osteoblastic differentiation over 7 days
[34]. During the final 3 days the medium was supplemented with
1,25D3 (10 nM) or with vehicle (ethanol, 0.1% v/v). TE-85 cells
and 16HBE14o- cells were incubated for 2 days in complete
growth medium. Subsequently for all preparations, the growth
medium was replaced with buffered saline solution (140 mM
NaCl, 10 mM HEPES titrated to pH 7.4 with NaOH, 2 mM
CaCl2, 1 mM MgCl2,5 mM KCl, 10 mM verapamil and 10 mM
felodopine) for 10 minutes and
45Ca uptake was assayed as
described previously [21]. Briefly, cells were incubated for 30 min
at 37C in 5% CO2 in buffer solution supplemented with forskolin
(10 mM) and IBMX (100 mM). During the last minute, cells were
exposed to
45CaCl2 (5 mCi/mg), washed three times in 30 seconds
with ice-cold buffered saline then lysed using 10% (w/v) sodium
dodecyl sulfate in buffered saline over 2 hours.
45Ca levels were
measured by Direct DPM scintillation counting (Packard Tri-Carb
1600 TR). Assay treatments were performed in sextuplicate and all
assays were repeated three times. Ca
2+ uptake was quantified as
picogram
45Ca per well. TRPV ion channel-mediated uptake was
calculated as the difference between uptake in the presence and
absence of ruthenium red (100 mM).
Gene expression assays
For analysis of gene expression, the osteoblastic cell lines
SaOS-2 and TE-85 were incubated with 1,25D3 (10 nM) in
molecular grade ethanol or with ethanol alone (0.1% v/v, vehicle
control) for 3 days. Primary murine calvarial osteoblasts were
prepared as previously described [35] from 2-day old C57BL/6
mice. For each preparation, recovered cells were grown to
confluence in two T75 tissue culture flasks in a-MEM complete
growth medium. Total RNA was extracted from cultured cells
using the GeneElute
TM Mammalian Total RNA MiniPrep Kit
(Sigma-Aldrich) immediately after discarding culture medium.
Total RNA was extracted from mouse tissues using Tri-reagent
(Sigma, 1 mL/100 mg tissue). All RNA extracts were treated
with DNase 1 (Sigma-Aldrich, 1 unit/mL) for 15 min at room
temperature. Following DNase treatment, RNA was quantified
and checked for purity using a NanoDrop ND-1000 Spectro-
photometer (NanoDrop Technologies Incorporated, Wilmington,
USA). All samples had an OD260/OD280 ratio of between 1.90
and 2.04. For all samples, 1 mg of total RNA was reverse
transcribed using SuperScript III reverse transcriptase (10 U/mL)
and oligo-dT20 primer (2.5 mM) in a total volume of 20 mL. 1 mL
of each cDNA sample was used in 10 mL qPCR assays to measure
expression of TRPV6 and the reference genes B2M/B2m,
GAPDH/Gapdh and ACTB/ActB using On Demand TaqMan
TM
Gene Expression Assays or previously published primer/probe
sets [18] as indicated in Table 1. Assays were performed in 384-
well microplates (Grenier bio-one, UK) using a 7900HT Fast
Real-Time PCR system (Applied Biosystems, UK). For each
template, TRPV6 and the appropriate reference genes were
assayed on the same plate in three assay replicates. For human
cell line templates, cDNA from LNCaP and CaCO-2 cells were
included as positive controls on the same plates. cDNA from
mouse duodenum was used as a positive control for TRPV6 gene
transcript expression in murine bone cells. Negative controls
of nuclease-free water and RT- templates were also included
in all assay runs. TRPV6 gene transcript expression was
calculated relative to reference genes based on the ddCT method:
ddCT =2
–dCT, where dCT=CT (gene of interest) – CT (reference
gene)[36].
Immunohistochemistry
Tissues were obtained from animals killed under a UK Home
Office Schedule 1 procedure and did not require local ethical
committee approval. Duodenum and femurs from 6 week old
male C57Bl/6J mice were trimmed of excess muscle and fixed in
10% buffered formalin (pH 7.0) for 48 hours. Bones were
subsequently decalcified in buffered 15% EDTA/0.5% parafor-
maldehyde (pH 8.0) solution at room temperature and main-
tained on a slowly oscillating platform for 4 weeks with weekly
changes of solution. Tissues were embedded in paraffin wax
immediately following fixation (duodenum) or decalcification
(femurs). Tissues were sectioned (3 mm) and mounted onto glass
slides then processed simultaneously. Sections were dewaxed in
xylene followed by 99% ethanol (2x 5 min each), then immersed
in ice-cold methanol for 10 minutes. Slides were treated with 1%
H2O2 (v/v) in methanol for 30 minutes then washed in three
changes of dH2O. TE-85 cells and LNCaP cells grown on glass
coverslips were fixed in ice-cold methanol for 10 minutes. Slides
with tissues and coverslips with cells were blocked using 5% (v/v)
rabbit serum in 1x PBS (blocking solution) for 30 minutes, then
incubated for 16 hours at 4C with either a goat polyclonal IgG
against TRPV6 (1:200) or normal goat IgG (1 mg/mL) diluted in
blocking solution. Samples were washed in PBS then incubated in
blocking solution supplemented with horseradish peroxidase-
conjugated rabbit anti-goat IgG (1:200) for 40 minutes then
washed in PBS. Samples were incubated in DAB peroxidase
substrate solution for 10 minutes and washed in dH2O before
Table 1. Primers for qPCR.
Target gene Primer/probe sequence or Assay ID
Trpv6
1 Forward: 59-ATCCGCCGCTATGCACA-39
Reverse: 59-AGTTTTTCTCCTGAATCTTTTTCCA-39
Probe: 59-TTCCAGCAACAAGATGGCCTCTACTCTGA-39
Gapdh Mm99999915_g1
2
ActB Mm00607939_s1
2
TRPV6 Hs00367960_m1
2
GAPDH Hs99999905_m1
2
ACTB Hs99999903_m1
2
B2M Hs99999907_m1
2
1. Published by Nijenhuis et al., 2003 [18].
2. On Demand TaqMan
TM Gene Expression Assays (Applied Biosystems, Life
Technologies Corporation).
doi:10.1371/journal.pone.0028166.t001
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coverslips were dehydrated in graded ethanol solutions (70%,
95%, 2x 99%) and xylene (5 min each), then mounted using
DePeX. Images were captured using a Leica DMI4000B
microscope equipped with a Leica DFC300FX digital camera
and LAS image capture software.
Statistical analysis
All results are expressed as means 6 standard error (SEM). For
electrophysiological data, currents corrected for capacitance across
the applied voltage range were fitted to the best fit line, which was
either linear or a 2
nd order polynomial (quadratic) function for
these data. Differences in current profiles between experimental
conditions were determined by comparing best fit models using the
extra sum of squares F-test in GraphPad Prism (La Jolla). Other
comparisons were undertaken using ANOVA, t-tests or the Mann-
Whitney U-test. Statistical significance was assumed at the 5%
level.
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